Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cx-601 in moderate active ulcerative colitis
NCT01914887Phase 2Unknown
- Sponsor
- Hospital La Paz Institute for Health Research
- Start
- Jun 2013
- Primary completion
- Dec 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of darvadstrocel in ulcerative colitis (UC), sponsored by Hospital La Paz Institute for Health Research. Status: unknown.
02
Drugs
darvadstrocel
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01914887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01914887.